IQVIA, a provider of healthcare data and research services, and Veeva Systems, a cloud software company serving over 1,000 life sciences clients, have announced new global partnerships covering both clinical and commercial operations. The agreement also resolves all prior legal disputes, creating a framework that enables customers to use both companies’ data, technology, and services together in a streamlined manner. In the commercial segment,

Become a Member

Members have access to all articles.

Membership
new data and software access agreements allow IQVIA data to be used with Veeva applications such as Veeva Network and Veeva AI, while Veeva data can be integrated into IQVIA’s analytics and orchestration offerings. In clinical research, IQVIA will join Veeva’s CRO Clinical Data Partner program, enabling its teams to use Veeva’s Clinical Suite, including Veeva EDC, to improve database builds, study locks, and trial execution.

Leaders from both firms highlighted the significance of the collaboration. Peter Gassner, CEO of Veeva, said, “We are committed to supporting frictionless product and services integration with IQVIA for the benefit of our joint customers and the industry overall.” Ari Bousbib, CEO of IQVIA, added, “IQVIA and Veeva’s partnerships bring together best-in-class capabilities in information, AI, technology, and services for our shared clients. This will enable IQVIA customers on Veeva platforms to accelerate clinical development, bring treatments to market more efficiently, and improve access to innovations for patients.” Together, the companies aim to deliver integrated solutions that help life sciences organizations drive greater efficiency across research and commercialization.

Read more